Inventages Venture Capital Investment Inc is an investment arm of Nestle SA specializing in PIPES, seed, early, mid, and late venture
Business Model:
Revenue: $5.4M
Employees: 2-10
Address: 2 Queen Anne’s Gate Buildings
City: London
State: england
Zip: SW1H 9BT
Country: GB
Inventages Venture Capital Investment Inc is an investment arm of Nestle SA specializing in PIPES, seed, early, mid, and late venture investments. The firm seeks to invest in middle market and mature companies. It provides mezzanine and bridge financing. The firm seeks to invest in health care, life sciences, cosmeceuticals, pharmaceuticals, enabling technologies and services, and diagnostic and medical devices. Within the pharmaceutical sector, it typically invests in small molecules, proteins, antibodies, vaccines, phytopharmaceuticals, natural compounds, botanicals, antibiotics, and therapeutics. Within the diagnostic sector, it focuses on genetic materials, biomarkers, pathological markers, genetic profiles, protein profiles, pharmacogenomics, food and environmental safety, genetically modified organism detection and trading, medical monitoring, diagnostic and analytical tools, and quality control. Within enabling technologies and services it primarily invests in novel packaging, process and production technologies, supply chain management, innovative materials and resources, delivery systems for active compounds, encapsulation and prevention, food services, extraction and fractionation of biological materials, consumer relation management, green biotechnology, smell and taste modifying technologies, genomics, proteomics, metabolomics, screen and characterization technologies, chemical and biological engineering, and innovative preventive and therapeutic concepts. It also invests in companies involved in the prevention of medical foods, nutraceuticals, cosmoceuticals, nutrition, innovative food, functional food, dietary and food supplements, oral and skin care, immune modulation and stimulation, and health and disease management.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2005 | Opsona | Series A | 6.6M |
2/2009 | Opsona | Series B | 22.8M |
9/2014 | AM Pharma | Series E | 15.8M |
1/2011 | Accera | Series D | 0 |
6/2005 | TriMed Research | Venture Round | 6.1M |
1/2004 | SelectX Pharmaceuticals Inc. | Series B | 8M |
11/2008 | Accera | Series C | 0 |
4/2005 | DNage | Series A | 1.9M |
10/2008 | Cognoptix | Series B | 0 |
1/2016 | XOLUTION | Venture Round | 0 |
3/2012 | Phosphate Therapeutics | Venture Round | 0 |
9/2011 | MSI Methylation Sciences | Series A | 18.4M |
10/2020 | Ripple Foods | Series D | 0 |
6/2009 | Opsona | Series B | 4.6M |
8/2007 | Food Quality Sensor International | Series B | 5.6M |
1/2010 | Tanfield Direct Ltd. | Venture Round | 6.5M |
2/2006 | Technologie BiolActis | Series A | 10M |
10/2006 | CMP Therapeutics | Series A | 5.7M |
2/2007 | Honest Tea | Private Equity Round | 12M |
5/2013 | Phagenesis | Series B | 0 |
1/2008 | GC-Rise Pharmaceutical | Series A | 4.7M |
7/2010 | CMP Therapeutics | Venture Round | 2M |
5/2008 | Steaz | Venture Round | 11M |
9/2014 | Cognoptix | Series D | 0 |
10/2011 | Phagenesis | Series B | 0 |
6/2011 | Shield Therapeutics | Series A | 0 |
4/2007 | DiObex | Series B | 24M |
2/2005 | Cavis microcaps | Series A | 5M |
1/2004 | Phytomedics | Series A | 7.5M |
6/2007 | Phytomedics | Series B | 9M |
7/2007 | MooBella | Series A | 25M |
9/2009 | MooBella | Series A | 18M |
8/2006 | Accera | Series B | 7.5M |
11/2004 | Cryolog | Series A | 2.8M |
10/2018 | Accera | Venture Round | 0 |
3/2007 | Cryolog | Series B | 7.9M |
8/2007 | AM Pharma | Series C | 3.4M |
10/2020 | Ripple Foods | Series D | 0 |
10/2018 | Accera | Venture Round | 0 |
1/2016 | XOLUTION | Venture Round | 0 |
9/2014 | Cognoptix | Series D | 0 |
9/2014 | AM Pharma | Series E | 0 |
5/2013 | Phagenesis | Series B | 0 |
3/2012 | Phosphate Therapeutics | Venture Round | 0 |
10/2011 | Phagenesis | Series B | 0 |
9/2011 | MSI Methylation Sciences | Series A | 0 |
6/2011 | Shield Therapeutics | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|